Chloroquine is grossly overdosed and overused but well tolerated in Guinea-Bissau

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 1, 2009, Pages 180-185

  Ursing, Johan ^a,b   Kofoed, Poul Erik ^b,c   Rodrigues, Amabelia ^b   Bergqvist, Yngve ^d   Rombo, Lars ^a,e,f  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Iganga Mayuge Health and Demographic Surveillance Site   (Guinea-Bissau)

^c KOLDING HOSPITAL   (Denmark)

^d DALARNA UNIVERSITY   (Sweden)

^e Department of Infectious Diseases ^*  (Sweden)

^f Sormland County Council   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; DEETHYLCHLOROQUINE;

ARTICLE; CHILD; CLINICAL PRACTICE; CONTROLLED STUDY; COUGHING; DIARRHEA; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HALF LIFE; DRUG MEGADOSE; DRUG MONITORING; DRUG OVERDOSE; DRUG TOLERABILITY; DRUG USE; FEMALE; FEVER; FOLLOW UP; GUINEA-BISSAU; HUMAN; INCIDENCE; INFANT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; NAUSEA; PALLOR; PARASITEMIA; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RECOMMENDED DRUG DOSE; SCHOOL CHILD; STOMACH PAIN; TREATMENT OUTCOME; VOMITING;

ANIMALS; ANTIMALARIALS; CHILD, PRESCHOOL; CHLOROQUINE; FEMALE; GUINEA-BISSAU; HUMANS; INFANT; MALE; QUESTIONNAIRES;

EID: 59749104092     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01111-08     Document Type: Article

References (25)

1. Abdel-Muhsin, A. M., M. J. Mackinnon, E. Ali, E.-K. A. Nassir, S. Suleiman, S. Ahmed, D. Walliker, and H. A. Babiker. 2004. Evolution of drug-resistance genes in Plasmodium falciparum in an area of seasonal malaria transmission in Eastern Sudan. J. Infect. Dis. 189:1239-1244.
2. Bray, P. G., M. Mungthin, I. M. Hastings, G. A. Biagini, D. K. Saidu, V. Lakshmanan, D. J. Johnson, R. H. Hughes, P. A. Stocks, P. M. O'Neill, D. A. Fidock, D. C. Warhurst, and S. A. Ward. 2006. PfCRT and the trans-vacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IX. Mol. Microbiol. 62:238-251.
3. Clemessy, J. L., P. Taboulet, J. R. Hoffman, P. Hantson, P. Barriot, C. Bismuth, and F. J. Baud. 1996. Treatment of acute chloroquine poisoning: a 5-year experience. Crit. Care Med. 24:1189-1195.
4. Frisk-Holmberg, M., Y. Bergqvist, E. Termond, and B. Domeij-Nyberg. 1984. The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects. Eur. J. Clin. Pharmacol. 26:521-530.
5. Hellgren, U., I. Johansson, F. Dias, O. Ericsson, J. Stenbeck, and L. Rombo. 1991. Chloroquine resistant Plasmodium falciparum malaria in Guinea-Bissau. Trans. R. Soc. Trop. Med. Hyg. 85:36.
6. Kofoed, P. E., F. Có, P. Johansson, F. Dias, C. Cabral, K. Hedegaard, P. Aaby, and L. Rombo. 2002. Treatment of uncomplicated malaria in children in Guinea-Bissau with chloroquine, quinine, and sulfadoxinepyrimethamine. Trans. R. Soc. Trop. Med. Hyg. 96:304-309.
7. Kofoed, P. E., F. Lopez, P. Johansson, A. Sandstrom, K. Hedegaard, P. Aaby, and L. Rombo. 2002. Treatment of children with Plasmodium falciparum malaria with chloroquine in Guinea-Bissau. Am. J. Trop. Med. Hyg. 67:28-31.
8. Kofoed, P. E., J. Ursing, A. Poulsen, A. Rodrigues, Y. Bergqvist, P. Aaby, and L. Rombo. 2007. Different doses of amodiaquine and chloroquine for treatment of uncomplicated malaria in children in Guinea-Bissau: implications for future treatment recommendations. Trans. R. Soc. Trop. Med. Hyg. 101:231-238.
9. Krishna, S., and N. J. White. 1996. Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Clin. Pharmacokinet. 30:263-299.
10. Laufer, M. K., P. C. Thesing, N. D. Eddington, R. Masonga, F. K. Dzinjalamala, S. L. Takala, T. E. Taylor, and C. V. Plowe. 2006. Return of chloroquine antimalarial efficacy in Malawi. N. Engl. J. Med. 355:1959-1966.
11. Lindegårdh, N., M. Forslund, M. D. Green, A. Kaneko, and Y. Bergqvist. 2002. Automated solid-phase extraction for determination of amodiaquine, cloroquine and metabolites in capillary blood on sampling paper by liquid chromatography. Chromatographia 55:5-12.
12. Looareesuwan, S., N. J. White, P. Chanthavanich, G. Edwards, D. D. Nicholl, C. Bunch, and D. A. Warrell. 1986. Cardiovascular toxicity and distribution kinetics of intravenous chloroquine. Br. J. Clin. Pharmacol. 22:31-36.
13. Mack, R. B. 1984. 4-Aminoquinolines can be dangerous to your health: chloroquine (Aralen) intoxication. N. C. Med. J. 45:245-246.
14. Ord, R., N. Alexander, S. Dunyo, R. Hallett, M. Jawara, G. Targett, C. J. Drakeley, and C. J. Sutherland. 2007. Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites. J. Infect. Dis. 196:1613- 1619.
15. Pussard, E., J. P. Lepers, F. Clavier, L. Raharimalala, J. Le Bras, M. Frisk-Holmberg, Y. Bergqvist, and F. Verdier. 1991. Efficacy of a loading dose of oral chloroquine in a 36-hour treatment schedule for uncomplicated Plasmodium falciparum malaria. Antimicrob. Agents Chemother. 35:406-409.
16. Rodrigues, A., J. A. Schellenberg, P. E. Kofoed, P. Aaby, and B. Greenwood. 2008. Changing pattern of malaria in Bissau, Guinea Bissau. Trop. Med. Int. Health 13:410-417.
17. Sanchez, C. P., W. D. Stein, and M. Lanzer. 2007. Is PfCRT a channel or a carrier? Two competing models explaining chloroquine resistance in Plasmodium falciparum. Trends Parasitol. 23:332-339.
18. Schellenberg, D., C. Menendez, J. J. Aponte, E. Kahigwa, M. Tanner, H. Mshinda, and P. Alonso. 2005. Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial. Lancet 365:1481-1483.
19. Schellenberg, D., C. Menendez, E. Kahigwa, J. Aponte, J. Vidal, M. Tanner, H. Mshinda, and P. Alonso. 2001. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet 357:1471-1477.
20. Smith, E. R., and W. Klein-Schwartz. 2005. Are 1-2 dangerous? Chloroquine and hydroxychloroquine exposure in toddlers. J. Emerg. Med. 28:437-443.
21. Sutherland, C. J., C. J. Drakeley, and D. Schellenberg. 2007. How is childhood development of immunity to Plasmodium falciparum enhanced by certain antimalarial interventions? Malar. J. 6:161.
22. Ursing, J., P. E. Kofoed, A. Rodrigues, L. Rombo, and J. P. Gil. 2007. Plasmodium falciparum genotypes associated with chloroquine and amodiaquine resistance in Guinea-Bissau. Am. J. Trop. Med. Hyg. 76:844-848.
23. Ursing, J., B. A. Schmidt, M. Lebbad, P. E. Kofoed, F. Dias, J. P. Gil, and L. Rombo. 2007. Chloroquine resistant P. falciparum prevalence is low and unchanged between 1990 and 2005 in Guinea-Bissau: an effect of high chloroquine dosage? Infect. Genet. Evol. 7:555-561.
24. WHO. 2006. Guidelines for the treatment of malaria. World Health Organization, Geneva, Switzerland.
25. Wootton, J. C., X. Feng, M. T. Ferdig, R. A. Cooper, J. Mu, D. I. Baruch, A. J. Magill, and X. Z. Su. 2002. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418:320-323.